Document is current
Any future updates will be listed below
-
Authors
Kissling, Lucas
Mollaysa, Amina
Janjuha, Sharan
Mathis, Nicolas
Marquart, Kim F.
Weber, Yanik
Moon, Woohyun J.
Lin, Paulo J. C.
Fan, Steven H. Y.
Muramatsu, Hiromi
Vadovics, Máté
Allam, Ahmed
Pardi, Norbert
Tam, Ying K.
Krauthammer, Michael
Schwank, Gerald
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01AI153064)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (201184, 185293)
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 25 April 2025
First Online: 8 May 2025
Declarations
:
: All animal experiments in this study comply with the Swiss Animal Welfare Act (AniWA; 455) and were performed in accordance with protocols approved by the Kantonales Veterinäramt Zürich (license number ZH159-20).
: Not applicable.
: G.S. is a scientific advisor to Prime Medicine. W.J.M., P.J.C.L, S.H.Y.F and Y.K.T are all employees of Acuitas Therapeutics Inc. All other authors have no interests to declare.
